|
CD164 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44249065417534E-15 |
| Normal-vs-Stage2 |
3.78129999978327E-07 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.183800E-01 |
| Stage1-vs-Stage3 |
6.102300E-02 |
| Stage1-vs-Stage4 |
1.609620E-02 |
| Stage2-vs-Stage3 |
4.431200E-01 |
| Stage2-vs-Stage4 |
3.046600E-01 |
| Stage3-vs-Stage4 |
6.503600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.62458935193399E-12 |
| Normal-vs-Asian |
9.183900E-04 |
| Caucasian-vs-AfricanAmerican |
1.361790E-01 |
| Caucasian-vs-Asian |
8.756600E-01 |
| AfricanAmerican-vs-Asian |
4.232800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.90656387846866E-13 |
| Male-vs-Female |
1.069810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70830016799073E-10 |
| Normal-vs-Age(41-60Yrs) |
1.63080660087189E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.16349999634835E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.573160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.066400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.330400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.301200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.175000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.484000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.842800E-04 |
| Normal-vs-Grade 2 |
6.81288359061227E-12 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.587000E-01 |
| Grade 1-vs-Grade 3 |
3.653600E-02 |
| Grade 1-vs-Grade 4 |
9.818500E-04 |
| Grade 2-vs-Grade 3 |
7.156500E-04 |
| Grade 2-vs-Grade 4 |
2.87780000052251E-07 |
| Grade 3-vs-Grade 4 |
7.401300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.54390003190986E-10 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
2.45339999982441E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62769797640294E-12 |
| Normal-vs-N1 |
2.00819999518487E-08 |
| N0-vs-N1 |
1.518400E-01 |
|
|
